백혈구 성분채집술 시장 보고서(2026년)

Leukapheresis is a medical procedure in which white blood cells (leukocytes) are separated and removed from a person's blood, while the remaining components, such as red blood cells and plasma, are returned to the body. This technique is employed to treat conditions with elevated white blood cell counts or to collect specific immune cells for research or therapeutic purposes.

The primary types of leukapheresis include granulocyte, lymphocyte, and monocyte apheresis. Granulocyte apheresis selectively isolates granulocytes (a type of white blood cell) from a patient's blood for therapeutic use. Products involved include leukapheresis devices, centrifugal devices, membrane separators, and disposables. Applications cover research, cancer studies, immunology research, therapeutic treatments, hematologic disorders, autoimmune diseases, and more, and are utilized by blood component providers, blood centers, academic and research institutes, pharmaceutical and biotechnology companies, as well as hospitals and transfusion centers.

Tariffs have impacted the leukapheresis market by increasing costs for imported apheresis devices, disposable kits, and precision centrifugation components. These impacts are most evident in therapeutic and research applications, particularly in North America, Europe, and Asia-Pacific regions with high device import dependence. Increased tariffs have raised procurement costs for hospitals, blood centers, and research institutes. Positively, tariffs have encouraged regional manufacturing of leukapheresis systems and improved supply chain localization.

The leukapheresis market research report is one of a series of new reports from The Business Research Company that provides leukapheresis market statistics, including leukapheresis industry global market size, regional shares, competitors with a leukapheresis market share, detailed leukapheresis market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis industry. This leukapheresis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The leukapheresis market size has grown strongly in recent years. It will grow from $72.02 billion in 2025 to $77.7 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to growth in hematologic disorders, expansion of cancer research programs, increasing use of apheresis in blood centers, advancements in centrifugation technologies, rising clinical research funding.

The leukapheresis market size is expected to see strong growth in the next few years. It will grow to $104.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growth in car-t and cell-based therapies, increasing investment in immunology research, rising demand for personalized medicine, expansion of biopharmaceutical manufacturing, technological advancements in apheresis automation. Major trends in the forecast period include rising use of leukapheresis in cell and gene therapies, increasing demand for immune cell collection in oncology, growing adoption of automated apheresis systems, expansion of leukapheresis in clinical research, increasing focus on patient-safe disposable apheresis kits.

The increasing prevalence of autoimmune diseases is expected to drive the growth of the leukapheresis market in the coming years. Autoimmune diseases are conditions in which the immune system mistakenly attacks the body's own healthy tissues. Reduced microbial exposure in early life and modern environmental factors are disrupting immune balance, contributing to the rise of these disorders. Leukapheresis helps manage autoimmune diseases by selectively removing harmful white blood cells that cause the immune system to attack the body. For example, in September 2025, according to GetValue.co, a US-based online digital platform, autoimmune diseases affect an estimated 3-10% of the global population, or roughly 600-800 million people worldwide. Consequently, the growing prevalence of autoimmune diseases is fueling the expansion of the leukapheresis market.

Major companies in the leukapheresis market are focusing on innovations such as GMP-grade leukopaks to improve the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are leukapheresis-derived products processed under strict good manufacturing practice (GMP) standards, ensuring high viability and functionality of the collected cells for therapeutic use. For example, in November 2024, Sanguine Biosciences, a US-based biotechnology company, launched LeukoCer, a GMP-grade leukopak designed to streamline workflows and accelerate cell therapy development. LeukoCer provides high-quality starting materials in fresh whole or half packs, produced according to rigorous GMP standards, enabling researchers to advance their work and bring new cell therapies to market more efficiently.

In July 2023, SCTbio, a Czech Republic-based contract development and manufacturing organization, partnered with Cyto-care.eu GmbH to improve the cryopreservation process for cell therapy in Europe. The collaboration focuses on enhancing the collection, cryopreservation, quality control, and logistics of leukapheresis materials, which are essential for manufacturing advanced cell therapy products (ATMPs). Cyto-care.eu GmbH is an Austria-based company specializing in supplying cell products for biomedical research, drug discovery, and cell and gene therapy.

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories

North America was the largest region in the leukapheresis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the leukapheresis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukapheresis market consists of revenues earned by entities providing services such as cell collection, cell processing and storage, and custom apheresis procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The leukapheresis market also includes sales of products such as apheresis machines, centrifugal and membrane-based systems, needles & catheters, and anticoagulants and solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses leukapheresis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The leukapheresis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Apheresis Type: Granulocyte Apheresis; Lymphocyte Apheresis; Monocyte Apheresis
• 2) By Product: Leukapheresis Devices; Centrifugal Devices; Membrane Separators; Leukapheresis Disposables
• 3) By Application: Research Application; Cancer Research; Immunology Research; Therapeutics Application; Hematologic Disorders; Autoimmune Diseases; Other Applications
• 4) By End User: Blood Component Providers And Blood Centers; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Transfusion Centers
• Subsegments:
• 1) By Granulocyte Apheresis: Neutrophil Apheresis; Eosinophil Apheresis; Basophil Apheresis
• 2) By Lymphocyte Apheresis: T-Cell Apheresis; B-Cell Apheresis; Natural Killer (NK) Cell Apheresis
• 3) By Monocyte Apheresis: Classical Monocytes; Non-Classical Monocytes; Intermediate Monocytes
• Companies Mentioned: Fresenius Kabi; Grifols S.A.; Terumo BCT Inc.; Nikkiso Co.; Haemonetics Corporation; Macopharma; MEDICA S.p.A; Caltag Medsystems Ltd.; Miltenyi Biotec; Puriblood Medical; Cytopheron Technologies; STEMCELL Technologies Inc.; Discovery Life Sciences; BioIVT LLC; StemExpress LLC; AllCells LLC; HemaCare Corporation; Key Biologics LLC; Immune Therapy Holdings AB; Cellsep Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Leukapheresis Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Leukapheresis Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Leukapheresis Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Leukapheresis Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Use Of Leukapheresis In Cell And Gene Therapies
  • 4.2.2 Increasing Demand For Immune Cell Collection In Oncology
  • 4.2.3 Growing Adoption Of Automated Apheresis Systems
  • 4.2.4 Expansion Of Leukapheresis In Clinical Research
  • 4.2.5 Increasing Focus On Patient-Safe Disposable Apheresis Kits

5. Leukapheresis Market Analysis Of End Use Industries

• 5.1 Hospitals And Transfusion Centers
• 5.2 Blood Component Providers And Blood Center
• 5.3 Pharmaceutical And Biotechnology Companies
• 5.4 Academic And Research Institutes
• 5.5 Cell Therapy Manufacturing Facilities

6. Leukapheresis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Leukapheresis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Leukapheresis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Leukapheresis Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Leukapheresis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Leukapheresis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Leukapheresis Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Leukapheresis Market Segmentation

• 9.1. Global Leukapheresis Market, Segmentation By Apheresis Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis
• 9.2. Global Leukapheresis Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables
• 9.3. Global Leukapheresis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications
• 9.4. Global Leukapheresis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers
• 9.5. Global Leukapheresis Market, Sub-Segmentation Of Granulocyte Apheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis
• 9.6. Global Leukapheresis Market, Sub-Segmentation Of Lymphocyte Apheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis
• 9.7. Global Leukapheresis Market, Sub-Segmentation Of Monocyte Apheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

10. Leukapheresis Market Regional And Country Analysis

• 10.1. Global Leukapheresis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Leukapheresis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Leukapheresis Market

• 11.1. Asia-Pacific Leukapheresis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Leukapheresis Market

• 12.1. China Leukapheresis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Leukapheresis Market

• 13.1. India Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Leukapheresis Market

• 14.1. Japan Leukapheresis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Leukapheresis Market

• 15.1. Australia Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Leukapheresis Market

• 16.1. Indonesia Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Leukapheresis Market

• 17.1. South Korea Leukapheresis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Leukapheresis Market

• 18.1. Taiwan Leukapheresis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Leukapheresis Market

• 19.1. South East Asia Leukapheresis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Leukapheresis Market

• 20.1. Western Europe Leukapheresis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Leukapheresis Market

• 21.1. UK Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Leukapheresis Market

• 22.1. Germany Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Leukapheresis Market

• 23.1. France Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Leukapheresis Market

• 24.1. Italy Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Leukapheresis Market

• 25.1. Spain Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Leukapheresis Market

• 26.1. Eastern Europe Leukapheresis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Leukapheresis Market

• 27.1. Russia Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Leukapheresis Market

• 28.1. North America Leukapheresis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Leukapheresis Market

• 29.1. USA Leukapheresis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Leukapheresis Market

• 30.1. Canada Leukapheresis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Leukapheresis Market

• 31.1. South America Leukapheresis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Leukapheresis Market

• 32.1. Brazil Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Leukapheresis Market

• 33.1. Middle East Leukapheresis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Leukapheresis Market

• 34.1. Africa Leukapheresis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Leukapheresis Market, Segmentation By Apheresis Type, Segmentation By Product, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Leukapheresis Market Regulatory and Investment Landscape

36. Leukapheresis Market Competitive Landscape And Company Profiles

• 36.1. Leukapheresis Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Leukapheresis Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Leukapheresis Market Company Profiles
  • 36.3.1. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Terumo BCT Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Nikkiso Co. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Haemonetics Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Leukapheresis Market Other Major And Innovative Companies

• Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories

38. Global Leukapheresis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Leukapheresis Market

40. Leukapheresis Market High Potential Countries, Segments and Strategies

• 40.1 Leukapheresis Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Leukapheresis Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Leukapheresis Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer